
News|Articles|August 20, 2014
Small Dark Spot on Forehead
A new dark spot on the forehead; overprescribing of benzodiazepines; alcohol and atrial fibrillation . . . can you answer the quiz questions on these topics?
Advertisement
Question 1:
An 50-year-old woman had a small dark spot on her forehead. She denied trauma to the affected area, and was not taking medication.
NEXT QUESTION »
Question 2:
NEXT QUESTION »
Question 3:
NEXT QUESTION »
For the answer, click here.
Question 4:
NEXT QUESTION »
Question 5:
ANSWER KEY »
ANSWER KEY:
Question 1. C
Question 2. B
Question 3. A
Question 4. B
Question 5. B
Advertisement
Related to this article

Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.

Physical activity was associated with up to 22% lower mortality and 19% lower stroke risk in adults with and without atrial fibrillation in a large Norwegian cohort study.

A Swedish observational study linked NOAC use to slower cognitive decline in individuals with atrial fibrillation and Alzheimer disease.

Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.

Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.

New American Society of Hematology guidelines raise ferritin cutoffs to catch iron deficiency sooner, including pregnancy and inflammation, and add TSAT for clearer diagnosis.

The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
The Shift From Off-Label Use to On-Label Agitation Therapy
5
